Related Experiment Video
Updated: Feb 14, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Unveiling FLNC variants: iPSC-derived myogenic cells as a model to study disease mechanisms
Nassam M Daya1,2, Anne Schänzer3,4, Andreas Hentschel5
1Ruhr University Bochum, BG University Hospital Bergmannsheil, Department of Neurology, Bochum, Germany, Ruhr-University Bochum, Bochum, Germany. nassam.daya@rub.de.
Background:
Filaminopathies, caused by pathogenic FLNC variants, are rare neuromuscular disorders characterized by protein aggregation, z-disk pathology and lead to progressive muscle weakness and/or cardiomyopathies.
Methods:
To address the lack of existing filaminopathy models in skeletal muscle, we developed a patient-specific cellular platform using induced pluripotent stem cells (iPSCs) harboring two truncating filamin C (FLNc) variants (p.Q1662X, p.Y2704X). Employing a developmental human skeletal muscle organoid hSMO model, we enrich for myogenic progenitor cells that are further differentiated into functional myotubes through 2D and 3D approaches (myotubes and musculoids).
Results:
The 2D myotubes exhibited poor sarcomeric organization and hallmarks of filaminopathies, including protein aggregation and proteostatic dysfunction, marked by elevated aggresome formation and an increased basal autophagic flux. The 3D musculoids revealed ultrastructural abnormalities and enabled the identification of novel disease-associated proteins involved in ER stress and protein folding (e.g. DNAJC10) through proteomic analysis. Proteomic findings were additionally validated in 2D cultures and in corresponding patient-derived muscle biopsies enhancing the model's translational value.
Conclusions:
Our model is suitable to monitor aspects of filaminopathies' pathogenesis and to investigate possible therapeutic interventions with quantitative readouts.
Insights
Researchers developed a patient-specific skeletal muscle organoid model for filaminopathies, rare neuromuscular disorders. This model reveals disease hallmarks and aids in identifying therapeutic targets for filamin C (FLNC) related muscle weakness and cardiomyopathies.
Area of Science:
- * Neuromuscular Biology
- * Stem Cell Biology
- * Disease Modeling
Background:
- * Filaminopathies are rare neuromuscular disorders caused by pathogenic FLNC variants.
- * These conditions lead to protein aggregation, z-disk pathology, progressive muscle weakness, and/or cardiomyopathies.
Purpose of the Study:
- * To develop a patient-specific cellular platform for studying filaminopathies in skeletal muscle.
- * To create a human skeletal muscle organoid (hSMO) model for filaminopathy research.
Main Methods:
- * Utilized induced pluripotent stem cells (iPSCs) from patients with truncating FLNC variants (p.Q1662X, p.Y2704X).
- * Developed hSMO models, enriching for myogenic progenitor cells differentiated into 2D myotubes and 3D musculoids.
Main Results:
- * 2D myotubes showed poor sarcomeric organization, protein aggregation, and proteostatic dysfunction.
- * 3D musculoids displayed ultrastructural abnormalities and identified novel disease-associated proteins (e.g., DNAJC10) via proteomic analysis.
- * Proteomic findings were validated in 2D cultures and patient muscle biopsies.
Conclusions:
- * The developed model effectively recapitulates key aspects of filaminopathy pathogenesis.
- * This model serves as a valuable tool for investigating therapeutic interventions with quantitative readouts.
More Related Videos
10:03Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
Published on: January 20, 2014
06:27Author Spotlight: Modeling Human Airway Remodeling and Viral Responses Using Isogenic Epithelial, Endothelial, and Immune Cells
Published on: December 6, 2024
Related Concept Videos
The Quantum-Mechanical Model of an Atom
Histone Variants at the Centromere
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
EPS and iPS Cells in Disease Research
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Mechanical Protein Functions